Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 399

1.

Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.

Zhang Y, Feng XH, Derynck R.

Nature. 1998 Aug 27;394(6696):909-13. Erratum in: Nature 1998 Dec 3;396(6710):491.

PMID:
9732876
2.
3.

Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.

Verrecchia F, Vindevoghel L, Lechleider RJ, Uitto J, Roberts AB, Mauviel A.

Oncogene. 2001 Jun 7;20(26):3332-40.

PMID:
11423983
4.

Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins.

Liang CL, Chen JL, Hsu YP, Ou JT, Chang YS.

J Biol Chem. 2002 Jun 28;277(26):23345-57.

PMID:
11971895
5.

Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis.

Yamamura Y, Hua X, Bergelson S, Lodish HF.

J Biol Chem. 2000 Nov 17;275(46):36295-302.

PMID:
10942775
6.

Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation.

Verrecchia F, Tacheau C, Schorpp-Kistner M, Angel P, Mauviel A.

Oncogene. 2001 Apr 26;20(18):2205-11.

PMID:
11402315
7.

Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription.

Shi X, Bai S, Li L, Cao X.

J Biol Chem. 2001 Jan 5;276(1):850-5.

PMID:
11042172
8.
9.

The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1.

Hall MC, Young DA, Waters JG, Rowan AD, Chantry A, Edwards DR, Clark IM.

J Biol Chem. 2003 Mar 21;278(12):10304-13.

PMID:
12525489
10.

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM.

EMBO J. 1998 Jun 1;17(11):3091-100.

PMID:
9606191
11.

The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.

Chipuk JE, Cornelius SC, Pultz NJ, Jorgensen JS, Bonham MJ, Kim SJ, Danielpour D.

J Biol Chem. 2002 Jan 11;277(2):1240-8.

PMID:
11707452
12.

Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.

Li C, Zhu NL, Tan RC, Ballard PL, Derynck R, Minoo P.

J Biol Chem. 2002 Oct 11;277(41):38399-408.

PMID:
12161428
13.

Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.

Cherlet T, Murphy LC.

Mol Cell Biochem. 2007 Dec;306(1-2):33-42.

PMID:
17660955
14.

Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.

Pardali K, Kurisaki A, Morén A, ten Dijke P, Kardassis D, Moustakas A.

J Biol Chem. 2000 Sep 22;275(38):29244-56.

PMID:
10878024
15.

TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.

He WX, Niu ZY, Zhao SL, Jin WL, Gao J, Smith AJ.

Arch Oral Biol. 2004 Nov;49(11):911-8.

PMID:
15353247
18.

Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis.

Arnulf B, Villemain A, Nicot C, Mordelet E, Charneau P, Kersual J, Zermati Y, Mauviel A, Bazarbachi A, Hermine O.

Blood. 2002 Dec 1;100(12):4129-38.

PMID:
12393612
19.

The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.

Lei S, Dubeykovskiy A, Chakladar A, Wojtukiewicz L, Wang TC.

J Biol Chem. 2004 Oct 8;279(41):42492-502.

PMID:
15292219
20.

Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.

Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K.

Oncogene. 2004 Mar 4;23(9):1656-67.

PMID:
15001984
Items per page

Supplemental Content

Support Center